U.S. implant manufacturers have recently received FDA’s clearance for products manufactured with Arcam’s EBM® technology. With the FDA clearance the companies are allowed to market their products on the important U.S. market.
The U.S. market for orthopaedic implants represents about half of the world-wide implant market. Up to now U.S. sales of orthopaedic products manufactured with Arcam’s EBM ® technology have been limited to patient-specific implants, which do not require clearance. Arcam already has systems installed for orthopaedic applications at four U.S. companies. These recent FDA clearances open up a market with a large potential, and are a further confirmation that implants produced with the Arcam technology fulfil the high standards and demands in the orthopaedic implant industry.
PLUS, a new case study highlights of integrated tabecular structure for Fix Ti-Por acetabular cup.
New orthopaedic implants improve people’s quality of life
The CE-certified Fixa Ti-Por acetabular cup...Manufactured with an integrated trabecular structure for improved osseointegration.
Latest from Today's Medical Developments
- Boston Scientific to acquire Penumbra, expanding cardiovascular portfolio
- Star Cutter introduces Double Pilot Reamer
- #80 Manufacturing Matters - Machining Strategies to Save Time and Improve your Process for MedTech Components with Kennametal Inc.
- Real-world parts and expert manufacturing advice
- Experts discuss the latest in toolholding technology
- How permanent magnets are powering medical innovation
- Forecasting the year ahead in design and manufacturing
- Tecomet, Orchid Orthopedic Solutions announce merger agreement